Daito Pharmaceuticals Amer Inc is categorized under Drug Brokers in Northbrook, IL and active since 2008.
Daito Pharmaceuticals Amer Inc was established in 2008, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Masamichi Oishi, Director at the company’s single location by writing to 633 Skokie Boulevard # 210, Northbrook, Illinois IL 60062 or by phoning (847) 205-0800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Daito Pharmaceuticals Amer Inc |
Contact Person: | Masamichi Oishi, Director |
Address: | 633 Skokie Boulevard # 210, Northbrook, Illinois 60062 |
Phone Number: | (847) 205-0800 |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Drug Brokers |
SIC Code: | 5122 |
NAICS Code: | 4242101 |
Share This Business: |
Daito Pharmaceuticals Amer Inc was started in 2008 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Masamichi Oishi, Director for inquiries that concern Daito Pharmaceuticals Amer Inc by calling the company number (847) 205-0800, as your correspondence is most welcome. Additionally, the physical location of the single location of Daito Pharmaceuticals Amer Inc can be found at the coordinates 42.14068,-87.79336 as well as the street address 633 Skokie Boulevard # 210 in Northbrook, Illinois 60062.
For its online presence, you may visit Daito Pharmaceuticals Amer Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.